PUBLICATIONS · 32072631
Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta-analysis of studies over the last ten years.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2020 May
- First author
- Dulucq S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dulucq S
- type
- Author
- name
- Astrugue C
- type
- Author
- name
- Etienne G
- type
- Author
- name
- Mahon FX
- type
- Author
- name
- Benard A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dulucq S
- type
- Author
- name
- Astrugue C
- type
- Author
- name
- Etienne G
- type
- Author
- name
- Mahon FX
- type
- Author
- name
- Benard A
- type
- Author
- bibliography ids
- nci-bib-c9bf12caae85a1e068f70c67
- book metadata
- content sha256
- 7a354bab03db9758834fa53622b8930c25f7accc9e6fb65af9b06c16724f2b70
- document type
- citation
- dois
- 10.1111/bjh.16408
- electronic publication date
- display
- 2020 Feb 19
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32072631
- immutable id
- pubmed:32072631@7a354bab03db9758834fa53622b8930c25f7accc9e6fb65af9b06c16724f2b70
- journal
- abbreviation
- Br J Haematol
- issn electronic
- 1365-2141
- issn print
- 0007-1048
- issue
- 3
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 452-468
- volume
- 189
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32072631
- provenance
- batch id
- 4c5003fbb78890e89ae1
- provider
- NCBI PubMed ESummary
- record sha256
- 344ec0f2192cb78b98c2a295a9df9f3f4084547a8bb6fbdfed2f7a87c3bd0c4a
- response sha256
- 890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
- retrieved at
- 2026-09-09T23:47:48.270700+00:00
- publication date
- display
- 2020 May
- precision
- month
- year
- 2020
- publication types
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
- Systematic Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta-analysis of studies over the last ten years.
Preserved source evidence · Not medical advice
Triangle